DESCRIPTION

Cefotec CV Dry Syrup (Cefpodoxime Proxetil 100 mg + Clavulanic  Acid 62.50 mg) is a combination medication containing cefpodoxime and clavulanic acid. It is used in children to treat bacterial infections affecting the lungs, nose, throat, ears, skin, and urinary tract. This medication works by interfering with the formation of the bacterial cell wall, ultimately leading to the destruction of the bacteria. Cefotec CV Dry Syrup  is not effective against infections caused by viruses.

INDICATION

• Intense bronchitis : Bronchitis is the inflammation and irritation of the bronchial tubes that carry air to the lungs. Cefotec CV Dry Syrup (Cefpodoxime Proxetil 100 mg + Clavulanic  Acid 62.50 mg) is used to treat bacterial bronchitis. It is also employed to manage acute exacerbations of chronic bronchitis (a long-term form of bronchitis) and to address recurrent bronchitis episodes that may occur following initial recovery.

• Sinusitis : Sinusitis is the swelling of layers that line your nose and encompassing sinuses. It is frequently caused by microscopic organisms and in some cases, infections and parasites. You may encounter a stuffed nose and torment or weight behind your eyes, nose, cheeks, or brow. Cefotec CV Dry Syrup (Cefpodoxime Proxetil 100 mg + Clavulanic  Acid 62.50 mg) is utilized to treat bacterial sinusitis and gives alleviation in three to eight weeks.

• Community obtained pneumonia : Community-acquired pneumonia (CAP) alludes to pneumonia (lung contamination) that is procured exterior the clinic. CAP can be bacterial or viral. Cefotec CV Dry Syrup (Cefpodoxime Proxetil 100 mg + Clavulanic  Acid 62.50 mg) is utilized to treat CAP caused by microbes.

• Pharyngitis/Tonsilitis : Pharyngitis and tonsillitis are contaminations that cause swelling and soreness in the throat and tonsils. If the disease influences both the throat and the tonsils, it would be called pharyngotonsillitis. Cefotec CV Dry Syrup (Cefpodoxime Proxetil 100 mg + Clavulanic  Acid 62.50 mg) is utilized to treat pharyngitis, tonsillitis, and/or pharyngotonsillitis.

• Urinary tract infection : An contamination in any portion of your urinary framework- the kidneys, bladder, ureters, or urethra is called urinary tract disease (UTI). UTIs are the most common diseases in people and ladies are at more prominent hazard of getting this disease. UTIs are caused by microscopic organisms and in a few cases, infections or organisms. Cefotec CV Dry Syrup (Cefpodoxime Proxetil 100 mg + Clavulanic  Acid 62.50 mg) is utilized to treat urinary tract contaminations caused by bacteria.

• Skin and delicate tissue infections : Skin and delicate tissue diseases happen when the microscopic organisms attack the skin and its supporting structures. Cefotec CV Dry Syrup (Cefpodoxime Proxetil 100 mg + Clavulanic  Acid 62.50 mg) is utilized to treat all skin diseases counting boil caused by microbes.

• Acute otitis media : Otitis media (AOM), is an contamination of the center ear (the region behind the eardrum), common in newborn children and youthful children. Cefotec CV Dry Syrup (Cefpodoxime Proxetil 100 mg + Clavulanic  Acid 62.50 mg) is utilized to treat intense otitis media caused by microscopic organisms.

MECHANISM OF ACTION 

Cefpodoxime Proxetil: This is a prodrug that converts into its active form, cefpodoxime, after absorption. Cefpodoxime is a third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis. It binds to penicillin-binding proteins (PBPs) in the bacterial cell wall, preventing the formation of cross-links in the peptidoglycan layer. This disruption weakens the cell wall, leading to bacterial cell lysis and death.

Clavulanic Acid: This is a beta-lactamase inhibitor. Beta-lactamase enzymes produced by certain bacteria can inactivate many beta-lactam antibiotics, including cephalosporins, rendering them ineffective. Clavulanic acid binds to and inhibits these beta-lactamase enzymes, protecting cefpodoxime from degradation. This enhances the antibiotic's effectiveness against beta-lactamase-producing bacteria, extending its spectrum of activity and improving its ability to treat bacterial infections.

DRUG INTERACTIONS

Drug-Drug Interactions: Cefotec CV Dry Syrup (Cefpodoxime Proxetil 100 mg + Clavulanic  Acid 62.50 mg) may have interaction with anticoagulants (e.g. warfarin), anti-gout (e.g. probenecid), diuretics (e.g. furosemide), and vitamin supplements (e.g. calcium, vitamin D).

Drug-Food Interactions: No interactions found/established.

Drug-Disease Interactions: Cefotec CV Dry Syrup (Cefpodoxime Proxetil 100 mg + Clavulanic  Acid 62.50 mg) may interact with conditions such as colitis (inflammation in the colon's lining), seizures, dialysis, and kidney or liver dysfunction.

PRECAUTIONS

When administering Cefotec CV Dry Syrup (Cefpodoxime proxetil 100 mg aur clavulanic acid 62.50 mg) to children, it is essential to consider several precautions. First, inform your healthcare provider if your child has any history of allergies to antibiotics, especially cephalosporins or penicillin. Monitor your child's liver and kidney function, as these organs are important for processing the medication, and consult your doctor if there are any pre-existing conditions. Ensure that you administer the correct dosage as prescribed, based on your child's weight and age. Additionally, watch for any side effects, such as gastrointestinal issues or rashes, and report them promptly to your healthcare provider. Encouraging your child to stay well-hydrated during treatment is also advisable. Always consult your pediatrician for personalized advice regarding this medication.

DISCLAIMER

The information on this website is provided for general informational purposes only and is not medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Consult a qualified healthcare provider for personalized advice. We do not endorse any specific products, treatments, or services mentioned.